Evonik
Tuesday, May 11, 2021
10:00 a.m. EDT / 4:00 p.m. CEST

Next-generation collagen revealed

Back to overview

Overview

Evonik has developed a next-generation collagen. The recombinant, fermentation-based collagen platform is non-animal derived and will provide medical, pharmaceutical, cell culture and tissue engineering markets with a highly soluble and highly pure form of collagen.

In this webinar, our experts Maria Montero Mirabet and Balaji Prabhu will show how the advanced material can mimic many attributes of natural collagen, making it suitable for a wide range of medical device and tissue engineering applications.

As a participant of this webinar you will learn about:
  • Fermentation-based production process and scale-up opportunities
  • Relevant clinical application areas of collagen
  • How an innovative biotech collagen can solve challenges and unmet needs of animal derived collagen
  • How to leverage the properties of a novel non-animal derived collagen
  • Application of various product forms, coatings, sponges, hydrogel, 3D bioinks

Experts featuring this session

Dr. Maria Montero Mirabet
Head of New Technology and Biomaterial Platforms
Evonik Health Care

Vita
Maria Montero Mirabet is Project Manager New Products & Materials at Evonik Health Care.

Maria studied Technical Chemistry in Girona (Spain) and Chemical Engineering in Darmstadt (Germany). She holds a Masters Degree in Food Biotechnology and a Ph.D in Biotechnology from the University of Girona.

In her previous position at HIPRA Scientific SL in Amer, Spain, she was responsible for managing projects for developing biological vaccines for animals.
Balaji Prabhu
Director Strategic Marketing Medical Device Solutions
Evonik Health Care

Vita
Balaji Prabhu is the Director of Strategic Marketing, Medical Device Solutions at Evonik. He is responsible for managing strategic growth of the Medical Device Biomaterials portfolio. Formerly as Director of Innovation, Balaji was one of the key contributors in the competency building for the Medical Device Competence Center (MDCC) in Birmingham, Alabama which is also the 3D printing Center of Excellence for bioresorbable polymers. Balaji has more than 15 years diverse experience in medical device and biomaterials space in various leadership roles from concept to commercialization. He holds graduate degrees in Materials Science Engineering, Executive Technology Management, and an Executive MBA in Innovation & Technology Management.

Related webinars in this series

This webinar is the first session of our 4-part webinar series on "Biomaterial solutions for implantable medical devices". For further details on the other three sessions please click on the respective webinar. To register for multiple sessions simply select them in the following registration form.
  • Bioresorbable polymers for 3D printing applications
    Wednesday, May 26, 2021 | 10:00 AM (EDT) / 4:00 PM (CEST)
  • Surface modification technologies to reduce thrombosis and prevent biofouling
    Wednesday, June 9, 2021 | 10:00 AM (EDT) / 4:00 PM (CEST)
  • From medical textiles to medical tubes: Discover the industry’s most versatile portfolio of bioresorbable polymers
    Wednesday, June 23, 2021 | 10:00 AM (EDT) / 4:00 PM (CEST)

Register now

Details

Webinar language
English

Venue

Online

Questions?

Julia Born
Market Communications Health Care
+49 6151 18 4984 E-Mail
Register now
Evonik Health Care
Company Information
Legal Notice
Privacy Policy